Publication | Open Access
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States
11
Citations
29
References
2023
Year
VNS was evaluated as a cost effective addition to the current standard of care in the treatment of DRE in the US Medicare context.
| Year | Citations | |
|---|---|---|
Page 1
Page 1